DAVIDSON, N.C.–(BUSINESS WIRE)—- $CW–Curtiss-Wright Corporation (NYSE: CW) today announced that the Board of Directors has authorized an additional $510 million for future share repurchases, increasing the total available authorization to $700 million. Under this new authorization, the Company will repurchase $100 million in additional shares immediately via a 10b5-1 program. The Company also declared a quarterly dividend of twenty-six cents ($0.26) per share, payable October 9, 2026, to stockholde
Month: September 2026
ARLINGTON, Va.–(BUSINESS WIRE)–Homes.com, a CoStar Group (NASDAQ: CSGP) leading online residential marketplace, found that today’s new-construction buyers approach the home buying process with more information and higher expectations than ever, often anchoring their decisions in having larger homes and long-term financial confidence, according to a newly published survey. The New Construction Market Landscape Study What New Home Buyers Want, conducted by Good Run Research and CMI Research and
DENVER–(BUSINESS WIRE)—- $YSS–York Space Systems to build Tomorrow.io DeepSky constellation.
CENTRAL ISLIP, N.Y.–(BUSINESS WIRE)–CVD Equipment Corporation (NASDAQ: CVV) (the “Company”) today announced a restructuring plan and leadership transition, following a thorough evaluation of strategic alternatives for its CVD equipment business by its Board of Directors (the “Board”). The restructuring plan includes: The Company will no longer pursue new system orders for its CVD equipment business. The Company is further reducing its workforce by approximately half, to a level necessary to m
KENNESAW, Ga.–(BUSINESS WIRE)–Yamaha Marine expands its Yamaha Blue Life series with a new feature highlighting photographer and freediver Ben Yavar, whose lifelong connection to the water has evolved into a career built around exploration, photography and the underwater world. “Ben Freediver” shares Yavar’s journey from a childhood fascination with the ocean to leading freediving and photography expeditions around the world. “Ben’s story reflects what Blue Life is all about: the connections,
AMSTERDAM–(BUSINESS WIRE)–Tommy Hilfiger, which is part of PVH Corp. [NYSE: PVH], staged a personal New York celebration today, presenting Spring 2027 at The Plaza Hotel. The legendary address — where Tommy Hilfiger once lived with his family — became the ultimate backdrop for modern prep, as uptown tradition and downtown cool passed through the same revolving doors. “For 40 years, I’ve been inspired by the style of New Yorkers — how the people of the city take the classics and make them thei
NEW YORK–(BUSINESS WIRE)–Elliptic, le leader mondial de la gestion des risques on-chain, publie aujourd’hui l’Elliptic Standard : huit principes régissant le risque agentique on-chain. Elliptic est à l’intersection de la criminalité financière et de la finance on-chain depuis 2013, assez longtemps pour reconnaître le passage aux transactions agentiques comme un point d’inflexion déterminant du risque de criminalité financière et pour être le premier à définir ce qu’il exige. Le financement on
OSLO, Norvegia–(BUSINESS WIRE)–Cyviz AS ha realizzato un centro di collaborazione flessibile per Swiss International Air Lines Ltd. (SWISS), progettato per supportare riunioni ibride, workshop, formazione, riunioni town hall ed eventi interni su ampia scala. Il progetto sottolinea il modo in cui le aziende globali stanno investendo in ambienti collaborativi affidabili, intuitivi e versatili mentre il lavoro ibrido diventa integrato nelle operazioni di tutti i giorni. Situato presso la sede di
MILWAUKEE, Sept. 10, 2026 (GLOBE NEWSWIRE) — Artisan Partners Asset Management Inc. (NYSE: APAM) today reported that its preliminary assets under management (“AUM”) as of August 31, 2026 totaled $183.5 billion. Artisan Funds and Artisan Global Funds accounted for $94.5 billion of total firm AUM, while separate accounts and other AUM1 accounted for $89.0 billion.
In early August, Artisan was notified that a long-standing sub-advisory client is diversifying our mandate from a single-manager to a multi-manager structure. Artisan will remain one of three managers under the new structure, but the change is expected to result in the rebalancing of approximately $6 billion from the Global Value strategy in September 2026. The anticipated impact on revenues is expected to be less than the corresponding reduction in assets under management given the nature of the mandate and its associated fee structure.
| PRELIMINARY ASSETS UNDER MANAGEMENT BY STRATEGY2 | |
| As of August 31, 2026 – ($ Millions) | |
| Growth Team | |
| Global Opportunities | $12,396 |
| Global Discovery | 1,912 |
| U.S. Mid-Cap Growth | 9,861 |
| U.S. Small-Cap Growth | 2,796 |
| Franchise | 1,065 |
| Global Equity Team | |
| Global Equity | 409 |
| Non-U.S. Growth | 16,518 |
| International Value Group | |
| International Value | 58,202 |
| International Explorer | 1,390 |
| Global Special Situations | 39 |
| Global Value Team | |
| Global Value | 39,962 |
| Select Equity | 1,091 |
| Sustainable Emerging Markets Team | |
| Sustainable Emerging Markets | 4,031 |
| Credit Team | |
| High Income | 14,482 |
| Credit Opportunities | 444 |
| Floating Rate | 307 |
| Custom Credit Solutions | 1,562 |
| Developing World Team | |
| Developing World | 3,397 |
| Antero Peak Group | |
| Antero Peak | 2,475 |
| Antero Peak Hedge | 250 |
| International Small-Mid Team | |
| Non-U.S. Small-Mid Growth | 4,150 |
| EMsights Capital Group | |
| Global Unconstrained | 2,362 |
| Emerging Markets Debt Opportunities | 1,616 |
| Emerging Markets Local Opportunities | 1,999 |
| Grandview Property Partners | |
| Grandview Property Partners3 | 774 |
| Total Firm Assets Under Management (“AUM”) | $183,490 |
1 Separate account and other AUM consists of the assets we manage in or through vehicles other than Artisan Funds or Artisan Global Funds. Separate account and other AUM includes assets we manage in traditional separate accounts, as well as assets we manage in Artisan-branded collective investment trusts, and in our own private funds.
2 AUM includes $499.8 million in aggregate for which Artisan Partners provides investment models to managed account sponsors (generally reported on a lag not exceeding one quarter).
3 Represents NAV plus uncalled and recallable capital.
ABOUT ARTISAN PARTNERS
Artisan Partners is a global multi-asset investment platform providing a broad range of high value-added investment strategies in growing asset classes to sophisticated clients around the world. Since 1994, the firm has been committed to attracting experienced, disciplined investment professionals to manage client assets. Artisan Partners’ autonomous investment teams oversee a diverse range of investment strategies across multiple asset classes. Strategies are offered through various investment vehicles to accommodate a broad range of client mandates.
Investor Relations Inquiries: 866.632.1770 or ir@artisanpartners.com
Source: Artisan Partners Asset Management Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver diseases, today announced senior management will present during the H.C. Wainwright & Co. 28th Annual Global Investment Conference at 8:30 a.m. Eastern Time on September 16, 2026.
A live webcast will be available on the Events and Presentations section of Assembly Bio’s website, and a replay will be accessible following the event. To register for the live webcast and replay, please visit: https://investor.assemblybio.com/events-presentations.
About Assembly Biosciences
Assembly Biosciences is a biotechnology company developing innovative small-molecule therapeutics aimed at advancing the treatment paradigm of serious viral and liver diseases and improving the lives of patients worldwide. Led by an accomplished leadership team in antiviral and liver disease drug development, Assembly Bio is committed to improving outcomes for people living with the chronic impacts of herpesvirus, hepatitis delta virus (HDV) infections, cholestatic liver diseases and hepatitis B virus (HBV). For more information, visit assemblybio.com.
Forward-Looking Statements
The information in this press release contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to materially differ. These risks and uncertainties include: Assembly Bio’s ability to realize the potential benefits of its collaboration with Gilead, including all financial aspects of the collaboration and equity investments; Assembly Bio’s ability to initiate and complete clinical studies involving its therapeutic product candidates, including studies contemplated by Assembly Bio’s collaboration with Gilead, including studies conducted by Gilead, in the currently anticipated timeframes or at all; safety and efficacy data from clinical or nonclinical studies may not warrant further development of product candidates; clinical and nonclinical data may not differentiate product candidates from other companies’ candidates; Assembly Bio’s ability to maintain financial resources and secure additional funding necessary to continue its research activities, clinical studies, and other business operations; potential effects of changes in government regulation; results of nonclinical studies may not be representative of disease behavior in a clinical setting and may not be predictive of the outcomes of clinical studies; and other risks identified from time to time in Assembly Bio’s reports filed with the U.S. Securities and Exchange Commission (the SEC). You are urged to consider statements that include the words may, will, would, could, should, might, believes, hopes, estimates, projects, potential, expects, plans, anticipates, intends, continues, forecast, designed, goal or the negative of those words or other comparable words to be uncertain and forward-looking. Assembly Bio intends such forward-looking statements to be covered by the safe harbor provisions contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. More information about Assembly Bio’s risks and uncertainties are more fully detailed under the heading “Risk Factors” in Assembly Bio’s filings with the SEC, including its most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Except as required by law, Assembly Bio assumes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
Contacts:
Investors:
Patrick Till
Meru Advisors
(484) 788-8560
investor_relations@assemblybio.com
Media:
Jamie Strachota
Sam Brown LLC
ASMBMedia@sambrown.com
